These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7221011)

  • 21. Termination of pregnancy by intramuscular administration of 15 (S)-15-methyl-prostaglandin in F2 alpha.
    Parewijck W; Thiery M; Decoster JM
    Z Geburtshilfe Perinatol; 1980 Oct; 184(5):366-70. PubMed ID: 6974438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of vaginal prostaglandin-E2 suppositories in septic abortion.
    Milano CT; Gleicher N
    Prostaglandins; 1980 Mar; 19(3):455-6. PubMed ID: 7384552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of labor with anencephalic fetus.
    Osathanondh R; Donnenfeld AE; Frigoletto FD; Driscoll SG; Ryan KJ
    Obstet Gynecol; 1980 Nov; 56(5):655-7. PubMed ID: 7432739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandins and abortion. I. intramuscular administration of 15-methyl prostaglandin F2alpha for induction of abortion in weeks 10 to 20 of pregnancy. World Health Organization Task Force on the Use of Prostaglandins for the Regulation of Fertility.
    Am J Obstet Gynecol; 1977 Nov; 129(6):593-6. PubMed ID: 920759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Termination of pregnancy in cases of intrauterine fetal death, missed abortion, molar and anencephalic pregnancy with intramuscular administration of 2a 2b dihomo 15(S) 15 methyl PGF2 alpha methyl ester--a multicentre study.
    Karim SM; Ratnam SS; Hutabarat H; Hanafiah J; Simanjuntak P; Teoh SK; Ong SK; Sen DK; Sinathuray TA
    Ann Acad Med Singap; 1982 Oct; 11(4):508-12. PubMed ID: 7165272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of prostaglandin action on the early pregnant human uterus.
    Csapo AI; Pulkkinen MO
    Prostaglandins; 1979 Sep; 18(3):479-90. PubMed ID: 531221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
    Scher J; Jeng DY; Kerenyi TD
    Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative blood coagulation studies in PGF2a- and 15-methyl-PGF2a-induced therapeutic abortion].
    During R; Junge WD; Klausch B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(3):502-7. PubMed ID: 6159287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative studies on the termination of intact and disturbed pregnancies by intramuscular application of 15(s)-15-methyl-prostaglandin F2alpha (author's transl)].
    Schridde H; Hickl EJ
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):845-8. PubMed ID: 700344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early pregnancy interruption with two 15-ME-PGF2a suppositories.
    Lauersen NH; Wilson KH
    Contraception; 1980 Mar; 21(3):273-82. PubMed ID: 7389352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of 15-methyl prostaglandin F2 alpha postpartum to contract the uterus in normal pregnant women.
    Nelson GH
    J Med Assoc Ga; 1983 Oct; 72(10):703-6. PubMed ID: 6644193
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM; Gutknecht GD
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical dilation with prostaglandin F2 alpha for first trimester abortion.
    Natrajan PK; Tzingounis VA
    South Med J; 1986 Jul; 79(7):830-1. PubMed ID: 3460179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
    Roy S; Brenner PF; Marrs RP; Mishell DR
    Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent inversion of the puerperal uterus managed with 15(s)-15-methyl prostaglandin F2 alpha and uterine packing.
    Heyl PS; Stubblefield PG; Phillippe M
    Obstet Gynecol; 1984 Feb; 63(2):263-4. PubMed ID: 6607434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of 15-methylated derivative of prostaglandin F2a for the therapeutic termination of pregnancy and management of late fetal death.
    Antsaklis A; Politis J; Diacomanolis E; Aravantinos D; Kaskarelis D
    Int Surg; 1984; 69(1):63-8. PubMed ID: 6735634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new abortion technique: intravaginal and intramuscular prostaglandin.
    Lauersen NH; Den T; Scher J; Iliescu C; Wilson KH
    Obstet Gynecol; 1981 Jul; 58(1):96-100. PubMed ID: 7243150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.